Clinical Trial Update: Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating irinotecan in combination with cisplatin for pediatric high-grade glioma; trial status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Hospital Sant Joan de Deu | Conditions: Pediatric High Risk Gliomas | Phase 2 | Status: COMPLETED